Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 6616 AL 6630

Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan

Hamaguchi T, Sakai K, Noguchi-Shinohara M, Nozaki I, Takumi I, Sanjo N, Sadakane A, Nakamura Y, Kitamoto T, Saito N, Mizusawa H, Yamada M.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1171-5. doi: 10.1136/jnnp-2012-304850. Epub 2013 Apr 17.

Caregivers of Alzheimer's patients and factors influencing institutionalization of loved ones: some considerations on existing literature

Sansoni J, Anderson KH, Varona LM, Varela G.

Ann Ig. 2013 May-Jun;25(3):235-46. doi: 10.7416/ai.2013.1926.

Late-life depression, mild cognitive impairment, and dementia

Richard E, Reitz C, Honig LH, Schupf N, Tang MX, Manly JJ, Mayeux R, Devanand D, Luchsinger JA.

JAMA Neurol. 2013 Mar 1;70(3):374-82. doi: 10.1001/jamaneurol.2013.603.

Subjective cognitive impairment: Towards early identification of Alzheimer disease

Garcia-Ptacek S, Eriksdotter M, Jelic V, Porta-Etessam J, Kåreholt I, Manzano Palomo S.

Neurologia. 2016 Oct;31(8):562-71. doi: 10.1016/j.nrl.2013.02.007. Epub 2013 Apr 17.

Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts

Trzepacz PT, Saykin A, Yu P, Bhamditipati P, Sun J, Dennehy EB, Willis B, Cummings JL; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2013 Jul;21(7):607-22. doi: 10.1016/j.jagp.2012.10.027. Epub 2013 Apr 18.

Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease

Falangola MF, Jensen JH, Tabesh A, Hu C, Deardorff RL, Babb JS, Ferris S, Helpern JA.

Magn Reson Imaging. 2013 Jul;31(6):840-6. doi: 10.1016/j.mri.2013.02.008. Epub 2013 Apr 18.

Progranulin mutations as risk factors for Alzheimer disease

Perry DC, Lehmann M, Yokoyama JS, Karydas A, Lee JJ, Coppola G, Grinberg LT, Geschwind D, Seeley WW, Miller BL, Rosen H, Rabinovici G.

JAMA Neurol. 2013 Jun;70(6):774-8. doi: 10.1001/2013.jamaneurol.393.

The epidemiology of frontotemporal dementia

Onyike CU, Diehl-Schmid J.

Int Rev Psychiatry. 2013 Apr;25(2):130-7. doi: 10.3109/09540261.2013.776523.

Phenotypic variety in the presentation of frontotemporal lobar degeneration

Shinagawa S.

Int Rev Psychiatry. 2013 Apr;25(2):138-44. doi: 10.3109/09540261.2012.743877.

Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration

Rascovsky K, Grossman M.

Int Rev Psychiatry. 2013 Apr;25(2):145-58. doi: 10.3109/09540261.2013.763341.

Schizophrenia and frontotemporal dementia: shared causation?

Harciarek M, Malaspina D, Sun T, Goldberg E.

Int Rev Psychiatry. 2013 Apr;25(2):168-77. doi: 10.3109/09540261.2013.765389.

Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes

Harciarek M, Cosentino S.

Int Rev Psychiatry. 2013 Apr;25(2):178-96. doi: 10.3109/09540261.2013.763340.

Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia

Kortte KB, Rogalski EJ.

Int Rev Psychiatry. 2013 Apr;25(2):237-45. doi: 10.3109/09540261.2012.751017.

The response of agitated behavior to pain management in persons with dementia

Husebo BS, Ballard C, Cohen-Mansfield J, Seifert R, Aarsland D.

Am J Geriatr Psychiatry. 2014 Jul;22(7):708-17. doi: 10.1016/j.jagp.2012.12.006. Epub 2013 Apr 20.

Which part of the Quick mild cognitive impairment screen (Qmci) discriminates between normal cognition, mild cognitive impairment and dementia?

O'Caoimh R, Gao Y, Gallagher PF, Eustace J, McGlade C, Molloy DW.

Age Ageing. 2013 May;42(3):324-30. doi: 10.1093/ageing/aft044.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias